Armen Shanafelt

Director, Aeglea BioTherapeutics.

Companies

Surface Oncology, Inc.Board member Apr 18, 2018 to Jun 10, 2022¹
Aeglea BioTherapeuticsBoard member Apr 6, 2016 to Jun 9, 2022²
Rein Therapeutics, Inc.Board member Jun 28, 2017 to Jun 25, 2018³
Protagonist Therapeutics, IncBoard member Aug 10, 2016 to Jun 12, 2018⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aeglea BioTherapeutics SYRE150,000 shares⁵$12.8M at $85.57Dec 13, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 13, 2021Bought 14,685 shares at $3.65 of Aeglea BioTherapeutics⁵
Dec 10, 2021Bought 13,516 shares at $3.65 of Aeglea BioTherapeutics⁵
Dec 9, 2021Bought 121,799 shares at $3.67 of Aeglea BioTherapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSurface Oncology, Inc., Board member
2
SEC EDGARAeglea BioTherapeutics, Board member
3
SEC EDGARRein Therapeutics, Inc., Board member
4
SEC EDGARProtagonist Therapeutics, Inc, Board member
5
SEC EDGARAeglea BioTherapeutics shares after the filing of Dec 13, 2021